Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cognition Therapeutics, Inc. (CGTX) had Free Cash Flow per Share of $-0.16 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.48M |
|
-- |
|
-- |
|
$13.78M |
|
$-13.78M |
|
$5.29M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-8.48M |
|
$-13.78M |
|
$-13.73M |
|
61.83M |
|
61.83M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$22.87M |
|
$0.19M |
|
$0.63M |
|
$23.50M |
|
$10.95M |
|
-- |
|
$0.28M |
|
$11.23M |
|
$12.27M |
|
$12.27M |
|
$12.27M |
|
61.98M |
|
| Cash Flow Statement Financials | |
$-9.88M |
|
-- |
|
$1.30M |
|
$25.01M |
|
$16.43M |
|
$-8.58M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-69.11% |
|
-69.11% |
|
-36.09% |
|
-69.11% |
|
$0.20 |
|
|
Free Cash Flow per Share |
$-0.16 |
$-0.16 |
|